Literature DB >> 9453592

Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum.

P C Okhuysen1, C L Chappell, C R Sterling, W Jakubowski, H L DuPont.   

Abstract

Healthy adults are susceptible to infection with small numbers of Cryptosporidium parvum oocysts, resulting in self-limited infection. We investigated if infection of humans with C. parvum is protective 1 year after primary exposure. At 1 year after a primary challenge with 30 to 10(6) oocysts, 19 healthy immunocompetent adults were rechallenged with 500 oocysts and monitored for the development of infection and/or illness. Oocyst excretion was quantitated by direct immunofluorescence with a C. parvum-specific monoclonal antibody, and anti-C. parvum antibodies in serum were detected by an enzyme-linked immunosorbent assay. Fewer subjects shed oocysts after the second exposure (3 of 19; 16%) than after the first exposure (12 of 19; 63%) (P < 0.005). Although the rates of diarrhea were comparable after each of the two exposures, the clinical severity as determined by the mean number of unformed stools passed was lower after reexposure (11.25 versus 8.62; P < 0.05). The number of anti-Cryptosporidium immunoglobulin G and A seroconversions increased after secondary exposure. However, the C. parvum serum antibody response did not correlate with the presence or absence of infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453592      PMCID: PMC107924     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes.

Authors:  V McDonald; H A Robinson; J P Kelly; G J Bancroft
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission.

Authors:  W R MacKenzie; W L Schell; K A Blair; D G Addiss; D E Peterson; N J Hoxie; J J Kazmierczak; J P Davis
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

3.  The infectivity of Cryptosporidium parvum in healthy volunteers.

Authors:  H L DuPont; C L Chappell; C R Sterling; P C Okhuysen; J B Rose; W Jakubowski
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

4.  Environmental sources of Cryptosporidium in an urban slum in northeastern Brazil.

Authors:  R D Newman; T Wuhib; A A Lima; R L Guerrant; C L Sears
Journal:  Am J Trop Med Hyg       Date:  1993-08       Impact factor: 2.345

5.  Evaluation of new anti-infective drugs for the treatment of acute infectious diarrhea. Infectious Diseases Society of America and the Food and Drug Administration.

Authors:  H L DuPont; M Cooperstock; M L Corrado; R Fekety; D M Murray
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

6.  Household epidemiology of Cryptosporidium parvum infection in an urban community in northeast Brazil.

Authors:  R D Newman; S X Zu; T Wuhib; A A Lima; R L Guerrant; C L Sears
Journal:  Ann Intern Med       Date:  1994-03-15       Impact factor: 25.391

7.  Intensity of infection in AIDS-associated cryptosporidiosis.

Authors:  R W Goodgame; R M Genta; A C White; C L Chappell
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

8.  A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply.

Authors:  W R Mac Kenzie; N J Hoxie; M E Proctor; M S Gradus; K A Blair; D E Peterson; J J Kazmierczak; D G Addiss; K R Fox; J B Rose
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

9.  Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers.

Authors:  C L Chappell; P C Okhuysen; C R Sterling; H L DuPont
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

10.  Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence.

Authors:  T L Kuhls; D A Mosier; D L Crawford; J Griffis
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

View more
  45 in total

1.  Serological responses to Cryptosporidium infection.

Authors:  T B Muller; F J Frost; G F Craun; R L Calderon
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Community study of infectious intestinal disease in England. Study underestimated morbidity due to specific pathogens.

Authors:  P R Hunter
Journal:  BMJ       Date:  1999-07-24

3.  Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; S Lahoti; A C White
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 4.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

5.  Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum.

Authors:  Abhineet Sheoran; Anthony Wiffin; Giovanni Widmer; Pradeep Singh; Saul Tzipori
Journal:  J Infect Dis       Date:  2012-01-25       Impact factor: 5.226

6.  Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigens.

Authors:  J W Priest; J P Kwon; D M Moss; J M Roberts; M J Arrowood; M S Dworkin; D D Juranek; P J Lammie
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

7.  Evaluation of recombinant oocyst protein CP41 for detection of cryptosporidium-specific antibodies.

Authors:  Sonia A Kjos; Mark Jenkins; Pablo C Okhuysen; Cynthia L Chappell
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

8.  Serological responses to Cryptosporidium-specific antigens in Czech populations with different water sources.

Authors:  F Kozisek; G F Craun; L Cerovska; P Pumann; F Frost; T Muller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

9.  Serologic response to human Cryptosporidium infections.

Authors:  F J Frost; G F Caun
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice.

Authors:  Alvaro J Benitez; Nina McNair; Jan R Mead
Journal:  Clin Vaccine Immunol       Date:  2009-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.